Medtronic completes acquisition of SPR Therapeutics expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain
Acquisition adds category-defining SPRINT® PNS technology to Medtronic’s pain therapy portfolio—the broadest in the industry
July 16, 2026